342 related articles for article (PubMed ID: 21877169)
1. Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings.
Tschumi S; Gugger M; Bucher BS; Riedl M; Simonetti GD
Pediatr Nephrol; 2011 Nov; 26(11):2085-8. PubMed ID: 21877169
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome.
Lapeyraque AL; Frémeaux-Bacchi V; Robitaille P
Pediatr Nephrol; 2011 Apr; 26(4):621-4. PubMed ID: 21161283
[TBL] [Abstract][Full Text] [Related]
3. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
Davin JC; Gracchi V; Bouts A; Groothoff J; Strain L; Goodship T
Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
[TBL] [Abstract][Full Text] [Related]
5. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B
Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055
[TBL] [Abstract][Full Text] [Related]
6. Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome.
Vilalta R; Lara E; Madrid A; Chocron S; Muñoz M; Casquero A; Nieto J
Pediatr Nephrol; 2012 Dec; 27(12):2323-6. PubMed ID: 22890512
[TBL] [Abstract][Full Text] [Related]
7. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
Fakhouri F; Delmas Y; Provot F; Barbet C; Karras A; Makdassi R; Courivaud C; Rifard K; Servais A; Allard C; Besson V; Cousin M; Châtelet V; Goujon JM; Coindre JP; Laurent G; Loirat C; Frémeaux-Bacchi V
Am J Kidney Dis; 2014 Jan; 63(1):40-8. PubMed ID: 24021908
[TBL] [Abstract][Full Text] [Related]
8. Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.
Mache CJ; Acham-Roschitz B; Frémeaux-Bacchi V; Kirschfink M; Zipfel PF; Roedl S; Vester U; Ring E
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1312-6. PubMed ID: 19556379
[TBL] [Abstract][Full Text] [Related]
9. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
Legendre CM; Licht C; Muus P; Greenbaum LA; Babu S; Bedrosian C; Bingham C; Cohen DJ; Delmas Y; Douglas K; Eitner F; Feldkamp T; Fouque D; Furman RR; Gaber O; Herthelius M; Hourmant M; Karpman D; Lebranchu Y; Mariat C; Menne J; Moulin B; Nürnberger J; Ogawa M; Remuzzi G; Richard T; Sberro-Soussan R; Severino B; Sheerin NS; Trivelli A; Zimmerhackl LB; Goodship T; Loirat C
N Engl J Med; 2013 Jun; 368(23):2169-81. PubMed ID: 23738544
[TBL] [Abstract][Full Text] [Related]
10. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
Sengul Samanci N; Ayer M; Ergen A; Ozturk S
Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
[TBL] [Abstract][Full Text] [Related]
11. Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation.
Cayci FS; Cakar N; Hancer VS; Uncu N; Acar B; Gur G
Pediatr Nephrol; 2012 Dec; 27(12):2327-31. PubMed ID: 22903728
[TBL] [Abstract][Full Text] [Related]
12. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
Tran H; Chaudhuri A; Concepcion W; Grimm PC
Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
[TBL] [Abstract][Full Text] [Related]
13. A complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab.
Schalk G; Kirschfink M; Wehling C; Gastoldi S; Bergmann C; Hoppe B; Weber LT
Pediatr Nephrol; 2015 Jun; 30(6):1039-42. PubMed ID: 25752761
[TBL] [Abstract][Full Text] [Related]
14. Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count.
Dorresteijn EM; van de Kar NC; Cransberg K
Pediatr Nephrol; 2012 Jul; 27(7):1193-5. PubMed ID: 22399074
[TBL] [Abstract][Full Text] [Related]
15. Eculizumab for atypical hemolytic uremic syndrome in pregnancy.
Ardissino G; Wally Ossola M; Maria Baffero G; Rigotti A; Cugno M
Obstet Gynecol; 2013 Aug; 122(2 Pt 2):487-489. PubMed ID: 23884270
[TBL] [Abstract][Full Text] [Related]
16. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome.
Cugno M; Gualtierotti R; Possenti I; Testa S; Tel F; Griffini S; Grovetti E; Tedeschi S; Salardi S; Cresseri D; Messa P; Ardissino G
J Thromb Haemost; 2014 Sep; 12(9):1440-8. PubMed ID: 24853860
[TBL] [Abstract][Full Text] [Related]
17. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
[TBL] [Abstract][Full Text] [Related]
18. Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy.
Fakhouri F; Frémeaux-Bacchi V; Loirat C
Eur J Intern Med; 2013 Sep; 24(6):492-5. PubMed ID: 23756030
[TBL] [Abstract][Full Text] [Related]
19. Cryptic activity of atypical hemolytic uremic syndrome and eculizumab treatment.
Belingheri M; Possenti I; Tel F; Paglialonga F; Testa S; Salardi S; Ardissino G
Pediatrics; 2014 Jun; 133(6):e1769-71. PubMed ID: 24843058
[TBL] [Abstract][Full Text] [Related]
20. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
Vondrák K; Seeman T
Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
